iBio Investor Relations Material
Latest events
Study Update
iBio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from iBio Inc
Access all reports
Bio iBionext, Inc., provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company offers development and manufacturing services for pharmaceuticals; laboratory research and diagnostics; protein research, engineering, and discovery; cell culture media products; pathogen detection; and bioproduction, packaging, and validation services. It sources raw materials from commercial suppliers primarily in North America. The company was founded in 1983 and is based in Westlake Village, California.
Key slides for iBio Inc
Study Update
iBio Inc
Study Update
iBio Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
IBIO
Country
🇺🇸 United States